Clarus Therapeutics to Present at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit
September 15 2021 - 9:05AM
Clarus Therapeutics Holdings, Inc. (Nasdaq:CRXT), a specialty
pharmaceutical company dedicated to providing solutions to unmet
medical needs by advancing androgen and metabolic therapies for men
and women, today announced that it will present virtually at the
Oppenheimer Fall Healthcare Life Sciences & MedTech Summit,
Monday, September 20, 2021, 2:05 p.m. ET.
The presentation will be webcast live and can be accessed
through the Investors section of Clarus Therapeutics’ website
at Investors.ClarusTherapeutics.com. An archived version of
the webcast will be available approximately two hours following the
live presentation for 90 days.
About Clarus Therapeutics Holdings, Inc. Clarus
Therapeutics Holdings, Inc. is a pharmaceutical company with
expertise in developing androgen and metabolic therapies for men
and women – including potential therapies for orphan indications.
Clarus Therapeutics’ first commercial product is JATENZO®. For more
information, visit www.clarustherapeutics.com and www.jatenzo.com.
Follow us on Twitter (@Clarus_Thera) and LinkedIn (Clarus
Therapeutics).
Clarus Investor Relations Contact:Kara
Stancellkstancell@clarustherapeutics.com(847) 562-4300 x 206
Clarus Therapeutics (NASDAQ:CRXT)
Historical Stock Chart
From Mar 2024 to Apr 2024
Clarus Therapeutics (NASDAQ:CRXT)
Historical Stock Chart
From Apr 2023 to Apr 2024